...
首页> 外文期刊>Chinese Medicine >Anti-malarial drug: the emerging role of artemisinin and its derivatives in liver disease treatment
【24h】

Anti-malarial drug: the emerging role of artemisinin and its derivatives in liver disease treatment

机译:抗疟疾药物:青蒿素的新兴作用及其衍生物在肝病治疗中

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Artemisinin and its derivatives belong to a family of drugs approved for the treatment of malaria with known clinical safety and efficacy. In addition to its anti-malarial effect, artemisinin displays anti-viral, anti-inflammatory, and anti-cancer effects in vivo and in vitro. Recently, much attention has been paid to the therapeutic role of artemisinin in liver diseases. Several studies suggest that artemisinin and its derivatives can protect the liver through different mechanisms, such as those pertaining to inflammation, proliferation, invasion, metastasis, and induction of apoptosis and autophagy. In this review, we provide a comprehensive discussion of the underlying molecular mechanisms and signaling pathways of artemisinin and its derivatives in treating liver diseases. Further pharmacological research will aid in determining whether artemisinin and its derivatives may serve as promising medicines for the treatment of liver diseases in the future.
机译:青蒿素及其衍生物属于一家批准用于治疗疟疾的药物家族,具有已知的临床安全性和疗效。 除了抗疟疾效应外,蒿蛋白还显示体内和体外抗病毒,抗炎和抗癌作用。 最近,甘氨酸在肝脏疾病中的治疗作用得到了很多关注。 几项研究表明,青蒿素及其衍生物可以通过不同的机制保护肝脏,例如与炎症,增殖,侵袭,转移和凋亡和自噬诱导有关的肝脏。 在本综述中,我们提供了对蒿蛋白的潜在分子机制和信号通路及其衍生物治疗肝脏疾病的综合讨论。 进一步的药理学研究将有助于确定氨化蛋白及其衍生物是否可作为未来治疗肝病的有希望的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号